UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel

BMC gastroenterology, 2018-05, Vol.18 (1), p.75-75, Article 75

2018

Volltextzugriff (PDF)

Nuclear hBD-1 accumulation in malignant salivary gland tumours

BMC cancer, 2008-10, Vol.8 (1), p.290-290, Article 290

2008

Volltextzugriff (PDF)

Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial

ESMO open, 2024-02, Vol.9 (2), p.102237-102237, Article 102237

2024

Volltextzugriff (PDF)

3006 Broad implementation of next generation sequencing based lung cancer genotyping in clinical routine within a nationwide health care provider network in Germany

European journal of cancer (1990), 2015-09, Vol.51, p.S597-S597

2015

Volltextzugriff (PDF)

3125 KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 2015-09, Vol.51, p.S645-S645

2015

Volltextzugriff (PDF)

3131 Clinical and molecular characteristics of non-small cell lung cancer in patients harboring CTNNB1 mutations

European journal of cancer (1990), 2015-09, Vol.51, p.S647-S647

2015

Volltextzugriff (PDF)

3129 Clinical and genetic presentation of high-level cMET-amplified Non-small cell lung cancer (NSCLC) with adenocarcinoma histology

European journal of cancer (1990), 2015-09, Vol.51, p.S646-S646

2015

Volltextzugriff (PDF)

605: Testing cancer related gene panels for high throughput parallel sequencing

European journal of cancer (1990), 2014-07, Vol.50, p.S145-S146

2014

Volltextzugriff (PDF)

Homologous recombination repair deficiency as a predictive biomarker : Basic mechanisms and detection methods

Der Pathologe, 2021-07, Vol.42 (4), p.391-398

2021

Volltextzugriff (PDF)

Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate

Clinical cancer research, 2006-03, Vol.12 (6), p.1743-1749

2006

Volltextzugriff (PDF)

Novel Germline Mutation of KIT Associated With Familial Gastrointestinal Stromal Tumors and Mastocytosis

Gastroenterology (New York, N.Y. 1943), 2005-09, Vol.129 (3), p.1042-1046

2005

Volltextzugriff (PDF)

Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing Retroperitoneal Lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas

European urology, 2023-02, Vol.83, p.S1061

2023

Volltextzugriff (PDF)

A0750 - Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing Retroperitoneal Lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas

European urology, 2023-02, Vol.83, p.S1061-S1061

2023

Volltextzugriff (PDF)

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

The lancet oncology, 2005-04, Vol.6 (4), p.249-251

2005

Volltextzugriff (PDF)

Association of Platelet-Derived Growth Factor Receptor α Mutations with Gastric Primary Site and Epithelioid or Mixed Cell Morphology in Gastrointestinal Stromal Tumors

The Journal of molecular diagnostics : JMD, 2004-08, Vol.6 (3), p.197-204

2004

Volltextzugriff (PDF)

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

BMC cancer, 2013-10, Vol.13 (1), p.472-472, Article 472

2013

Volltextzugriff (PDF)

Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group

Urologe. Ausgabe A, 2020-03, Vol.59 (3), p.318

2020

Volltextzugriff (PDF)

The 4G/5G promotor polymorphism of the plasminogen activator inhibitor‐1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients

Clinical cardiology (Mahwah, N.J.), 2001-09, Vol.24 (9), p.585-591

2001

Volltextzugriff (PDF)

Correlation of the c-kit mutational status of gastrointestinal stromal tumors with the clinical response to the tyrosine kinase inhibitor imatinib

Pathology, research and practice, 2004, Vol.200 (4), p.316-317

2004

Volltextzugriff (PDF)

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat

The journal of pathology. Clinical research, 2016-04, Vol.2 (2), p.59-71

2016

Volltextzugriff (PDF)

Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer

Modern pathology, 2005-03, Vol.18 (3), p.431-438

2005

Volltextzugriff (PDF)

Benign metastasizing leiomyoma: A cytogenetically balanced but clonal disease

Human pathology, 2000, Vol.31 (1), p.126-128

2000

Volltextzugriff (PDF)

Are sarcoma centers needed in Germany

Der Pathologe, 2011-02, Vol.32 (1), p.72-75

2011

Volltextzugriff (PDF)

Molekulare Diagnostik bei nicht-hämatologischen malignen Erkrankungen

Der Onkologe, 2005-08, Vol.11 (8), p.873-888

2005

Volltextzugriff (PDF)

Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study

European journal of gynaecological oncology, 2020-02, Vol.41 (1), p.80

2020

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Aktive Filter

KollektionOvid SocietyJournals and Single Titles

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(183)

Publikationsform

Sprache

Englisch
(155)
Deutsch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(99)
Humans
(87)
Pathology
(63)
Mutation
(59)
Oncology
(44)
Female
(36)
Tumors
(35)
Medicine
(33)
Medicine & Public Health
(33)
Male
(31)
Middle Aged
(30)
Aged
(27)
Lung Cancer
(26)
Lung Neoplasms - Genetics
(24)
Adult
(21)
Kinases
(21)
Gastrointestinal Stromal Tumors - Genetics
(20)
Immunohistochemistry
(20)
Cancer
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel

Nuclear hBD-1 accumulation in malignant salivary gland tumours

Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial

3006 Broad implementation of next generation sequencing based lung cancer genotyping in clinical routine within a nationwide health care provider network in Germany

3125 KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC)

3131 Clinical and molecular characteristics of non-small cell lung cancer in patients harboring CTNNB1 mutations

3129 Clinical and genetic presentation of high-level cMET-amplified Non-small cell lung cancer (NSCLC) with adenocarcinoma histology

605: Testing cancer related gene panels for high throughput parallel sequencing

Homologous recombination repair deficiency as a predictive biomarker : Basic mechanisms and detection methods

Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate

Novel Germline Mutation of KIT Associated With Familial Gastrointestinal Stromal Tumors and Mastocytosis

Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing Retroperitoneal Lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas

A0750 - Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing Retroperitoneal Lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

Association of Platelet-Derived Growth Factor Receptor α Mutations with Gastric Primary Site and Epithelioid or Mixed Cell Morphology in Gastrointestinal Stromal Tumors

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group

The 4G/5G promotor polymorphism of the plasminogen activator inhibitor‐1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients

Correlation of the c-kit mutational status of gastrointestinal stromal tumors with the clinical response to the tyrosine kinase inhibitor imatinib

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat

Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer

Benign metastasizing leiomyoma: A cytogenetically balanced but clonal disease

Are sarcoma centers needed in Germany

Molekulare Diagnostik bei nicht-hämatologischen malignen Erkrankungen

Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study

Aktive Filter

Suchergebnisse filtern